AXLA

H.C. Wainwright analyst Ed Arce maintained a Buy rating on Axcella Health (AXLA - Research Report) today and set a price target of $8.00. The company's shares closed last Friday at $2.33.According to TipRanks, Arce is a 4-star analyst with an average return of 8.3% and a 39.95% success rate. Arce covers the Healthcare sector, focusing on stocks such as CymaBay Therapeutics, Assembly Biosciences, and Pliant Therapeutics.Axcella Health has an analyst consensus of Strong Buy, with a price target consensus of $8.25, implying a 254.08% upside from current levels. In a report released yesterday, Chardan Capital also reiterated a Buy rating on the stock with a $7.00 price target.
https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-axcella-health-axla?utm_source=advfn.com&utm_medium=referral